Among them, the most widely used ligands for NP-based imaging and therapy of PCa are PSMA-targeting small molecules [33,35,36,37,39,40,44,47,48], antibodies [34,35,38,50], antibody single-chain fragments (scFv) [42], diabodies (cys-DB) [43], and aptamers [34]. Here, FOLH1 is linked to posterior cortical atrophy.